CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production

J Immunol. 1992 Dec 15;149(12):3795-801.

Abstract

Ag-presenting cells provide at least two distinct signals for T cell activation. T cell receptor-dependent stimulation is provided by presentation of a specific peptide Ag in association with MHC molecules. In addition, APC also supply costimulatory signals required for T cell activation that are neither Ag- nor MHC restricted. One such costimulatory signal is mediated via the interaction of B7 on APC with the CD28 receptor on T cells. Recently, CTLA-4 has been shown to be a second B7 receptor on T cells. In the present report, we have examined the expression of CD28 and CTLA-4 on a panel of resting and activated normal T cell subsets and T cell clones by RNA blot analysis in an attempt to determine whether their expression defines reciprocal or overlapping subsets. CD28 was detected in resting T cells, whereas CTLA-4 was not. After stimulation with PHA and PMA for 24 h, CTLA-4 mRNA was expressed in both the CD4+ and CD8+ subsets as well as in CD28+ T cells. We examined 37 human and six murine T cell clones that had been previously characterized for their cytokine production. After activation, CTLA-4 and CD28 mRNA were coexpressed in 36 of 37 human T cell clones and all six murine T cell clones. These included T cells of CD4+8-, CD4-8+, and CD4-8- phenotypes as well as clones with Th1 and Th2 cytokine profiles. In contrast, CD28 but not CTLA-4 mRNA was detected in leukemic T cell lines and myelomas. CTLA-4 and B7 mRNA but not CD28 mRNA was detected in two long term HTLV-I-transformed T cell lines. These data demonstrate that CD28 and CTLA-4 mRNA are coexpressed in most activated T cells and T cell clones, providing evidence that they do not define reciprocal subsets. Moreover, they are consistent with the hypothesis that B7 transmits its signal through a single receptor, CD28, on resting T cells, and multiple receptors, CD28 and CTLA-4, on activated T cells.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Abatacept
  • Animals
  • Antigens, CD / biosynthesis*
  • Antigens, Differentiation / biosynthesis*
  • Antigens, Differentiation, T-Lymphocyte / biosynthesis*
  • Antigens, Surface / biosynthesis
  • B7-1 Antigen
  • Base Sequence
  • Blotting, Northern
  • CD28 Antigens
  • CTLA-4 Antigen
  • Cell Adhesion Molecules / biosynthesis
  • Cell Line
  • Humans
  • Immunoconjugates*
  • Interferon-gamma / biosynthesis
  • Interleukins / biosynthesis
  • Leukemia, T-Cell / immunology
  • Lymphocyte Activation / immunology*
  • Lymphokines / biosynthesis*
  • Mice
  • Molecular Sequence Data
  • Oligonucleotide Probes
  • Polymerase Chain Reaction
  • RNA, Messenger / biosynthesis*
  • T-Lymphocytes / metabolism*
  • Tumor Necrosis Factor-alpha / biosynthesis

Substances

  • Antigens, CD
  • Antigens, Differentiation
  • Antigens, Differentiation, T-Lymphocyte
  • Antigens, Surface
  • B7-1 Antigen
  • CD28 Antigens
  • CTLA-4 Antigen
  • CTLA4 protein, human
  • Cell Adhesion Molecules
  • Ctla4 protein, mouse
  • Immunoconjugates
  • Interleukins
  • Lymphokines
  • Oligonucleotide Probes
  • RNA, Messenger
  • Tumor Necrosis Factor-alpha
  • Abatacept
  • Interferon-gamma